Huang Li reduced his holdings in INNOGEN-B (02591) by 1.12 million shares at an average price of approximately HKD 4.34 per share.
On August 20, Huang Li reduced his holdings in Yinnuo Pharmaceutical-B (02591) by 1.12 million shares, at a price of HKD 4.3369 per share, for a total amount of approximately HKD 4.8573 million.
According to the latest data from the Hong Kong Stock Exchange, on August 20, Huang Li reduced his holdings of INNOGEN-B (02591) by 1.12 million shares at a price of HKD 4.3369 per share, totaling approximately HKD 4.8573 million. After the reduction, the latest number of shares held is approximately 37.4911 million, with the latest shareholding ratio at 8.92%.
Related Articles
BLUE MOON GROUP (06993) will distribute an interim dividend of HKD 0.08 per share on September 29.
Preview of US Stock Market | All three major stock index futures fell, and Walmart dropped after earnings. Institutions warn that the U.S. Treasury's increased long-term bond repurchases will not stop the yield curve from steepening.
ZHIHU-W (02390) repurchased 84,000 shares for $88,600 on August 19.
BLUE MOON GROUP (06993) will distribute an interim dividend of HKD 0.08 per share on September 29.
Preview of US Stock Market | All three major stock index futures fell, and Walmart dropped after earnings. Institutions warn that the U.S. Treasury's increased long-term bond repurchases will not stop the yield curve from steepening.
ZHIHU-W (02390) repurchased 84,000 shares for $88,600 on August 19.
RECOMMEND
